Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891584426> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2891584426 abstract "3064Background: Clinical trials supported the FDA approval of anti-PD1 antibodies nivolumab and pembrolizumab for treatment of advanced melanoma, renal cell carcinoma, and non-small cell lung cance..." @default.
- W2891584426 created "2018-09-27" @default.
- W2891584426 creator A5006005284 @default.
- W2891584426 creator A5008409227 @default.
- W2891584426 creator A5031405616 @default.
- W2891584426 creator A5032987754 @default.
- W2891584426 creator A5035539932 @default.
- W2891584426 creator A5045975575 @default.
- W2891584426 creator A5049245990 @default.
- W2891584426 creator A5055165247 @default.
- W2891584426 creator A5059298173 @default.
- W2891584426 creator A5061285204 @default.
- W2891584426 creator A5069923958 @default.
- W2891584426 creator A5081368898 @default.
- W2891584426 creator A5081588858 @default.
- W2891584426 date "2016-05-20" @default.
- W2891584426 modified "2023-09-26" @default.
- W2891584426 title "Toxicity profile of approved anti-PD1 monoclonal antibodies in solid tumors: A systematic review and meta-analysis of randomized clinical trials." @default.
- W2891584426 doi "https://doi.org/10.1200/jco.2016.34.15_suppl.3064" @default.
- W2891584426 hasPublicationYear "2016" @default.
- W2891584426 type Work @default.
- W2891584426 sameAs 2891584426 @default.
- W2891584426 citedByCount "1" @default.
- W2891584426 countsByYear W28915844262020 @default.
- W2891584426 crossrefType "journal-article" @default.
- W2891584426 hasAuthorship W2891584426A5006005284 @default.
- W2891584426 hasAuthorship W2891584426A5008409227 @default.
- W2891584426 hasAuthorship W2891584426A5031405616 @default.
- W2891584426 hasAuthorship W2891584426A5032987754 @default.
- W2891584426 hasAuthorship W2891584426A5035539932 @default.
- W2891584426 hasAuthorship W2891584426A5045975575 @default.
- W2891584426 hasAuthorship W2891584426A5049245990 @default.
- W2891584426 hasAuthorship W2891584426A5055165247 @default.
- W2891584426 hasAuthorship W2891584426A5059298173 @default.
- W2891584426 hasAuthorship W2891584426A5061285204 @default.
- W2891584426 hasAuthorship W2891584426A5069923958 @default.
- W2891584426 hasAuthorship W2891584426A5081368898 @default.
- W2891584426 hasAuthorship W2891584426A5081588858 @default.
- W2891584426 hasConcept C126322002 @default.
- W2891584426 hasConcept C143998085 @default.
- W2891584426 hasConcept C159654299 @default.
- W2891584426 hasConcept C168563851 @default.
- W2891584426 hasConcept C203014093 @default.
- W2891584426 hasConcept C29730261 @default.
- W2891584426 hasConcept C535046627 @default.
- W2891584426 hasConcept C542903549 @default.
- W2891584426 hasConcept C71924100 @default.
- W2891584426 hasConcept C95190672 @default.
- W2891584426 hasConcept C98274493 @default.
- W2891584426 hasConceptScore W2891584426C126322002 @default.
- W2891584426 hasConceptScore W2891584426C143998085 @default.
- W2891584426 hasConceptScore W2891584426C159654299 @default.
- W2891584426 hasConceptScore W2891584426C168563851 @default.
- W2891584426 hasConceptScore W2891584426C203014093 @default.
- W2891584426 hasConceptScore W2891584426C29730261 @default.
- W2891584426 hasConceptScore W2891584426C535046627 @default.
- W2891584426 hasConceptScore W2891584426C542903549 @default.
- W2891584426 hasConceptScore W2891584426C71924100 @default.
- W2891584426 hasConceptScore W2891584426C95190672 @default.
- W2891584426 hasConceptScore W2891584426C98274493 @default.
- W2891584426 hasLocation W28915844261 @default.
- W2891584426 hasOpenAccess W2891584426 @default.
- W2891584426 hasPrimaryLocation W28915844261 @default.
- W2891584426 isParatext "false" @default.
- W2891584426 isRetracted "false" @default.
- W2891584426 magId "2891584426" @default.
- W2891584426 workType "article" @default.